LIF and bronchopulmonary dysplasia: The lungs of MSC treated mice had significantly lower levels of BPD injury related to proteins associated with immunomodulation (CX3CL1, TNFα, TIM‐1, hepassocin, neprilysin), cell survival (osteoprotegerin), and wound healing (MMP‐2, LIF).